[CUTR] Cutera, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 17.2 Change: 0.15 (0.88%)
Ext. hours: Change: 0 (0%)

chart CUTR

Refresh chart

Strongest Trends Summary For CUTR

CUTR is in the medium-term up 92% in 3 months and up 153% in 8 months. In the long-term down -23% below S&P in 2 years and up 346% in 13 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Cutera, Inc., a medical device company, is engaged in the design, development, manufacture, marketing, and service of laser and other energy based aesthetics systems for practitioners worldwide. The company offers products based on platforms/systems, such as Xeo, a multi-application platform on which customers purchase hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin rejuvenation by treating discoloration, improving texture, reducing pore size, and treating fine lines and laxity; and GenesisPlus, which is a laser system for performing aesthetic skin procedures and for the temporary increase of clear nail in patients with onychomycosis or toenail fungus. Its platforms also comprise ExcelV, a vascular platform that is primarily designed for the market of dermatologists and plastic surgeons; and truSculpt, which is a radio frequency platform designed for the non-invasive body contouring market. The company?s products include CoolGlide, Solera, and VariLite, as wel

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 7.6% Sales Growth - Q/Q-25.21% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-10.23% ROE-13.55% ROI-13.38%
Current Ratio4.82 Quick Ratio4.25 Long Term Debt/Equity0.01 Debt Ratio0.26
Gross Margin54.93% Operating Margin-13.04% Net Profit Margin-13.14% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities1.39 M Cash From Investing Activities8.28 M Cash From Operating Activities-6.01 M Gross Profit10.02 M
Net Profit-3.64 M Operating Profit-3.6 M Total Assets104.02 M Total Current Assets100.04 M
Total Current Liabilities20.77 M Total Debt Total Liabilities25.45 M Total Revenue19.07 M
Technical Data
High 52 week40.95 Low 52 week12.35 Last close33.61 Last change33.85%
RSI82.56 Average true range1.73 Beta0.7 Volume31.58 K
Simple moving average 20 days33.05% Simple moving average 50 days54.87% Simple moving average 200 days82.4%
Performance Data
Performance Week33.8% Performance Month40.69% Performance Quart84.57% Performance Half140.93%
Performance Year-1.22% Performance Year-to-date97.47% Volatility daily6.48% Volatility weekly14.5%
Volatility monthly29.71% Volatility yearly102.91% Relative Volume319.7% Average Volume115.06 K
New High0.58% New Low

News

2019-09-12 16:00:00 | Cutera Receives Additional Approval from Health Canada for its truSculpt® iD Body Sculpting Technology

2019-09-10 10:27:02 | Cutera Sees Hammer Chart Patteern: Time to Buy?

2019-09-09 08:30:00 | Cutera to Present at Upcoming Investor Conferences

2019-09-06 08:31:37 | Edited Transcript of CUTR earnings conference call or presentation 8-Aug-19 8:30pm GMT

2019-08-30 07:56:11 | New Strong Buy Stocks for August 30th

2019-08-28 09:23:01 | Laser Systems & Components Industry Outlook: Prospects Bright

2019-08-26 08:14:12 | New Strong Buy Stocks for August 26th

2019-08-22 10:34:37 | What Kind Of Share Price Volatility Should You Expect For Cutera, Inc. NASDAQ:CUTR?

2019-08-12 16:05:00 | Cutera Announces Planned Retirement of David B. Apfelberg, M.D., as Member of the Board of Directors

2019-08-09 16:29:00 | Why Appian, Chuy's Holdings, and Cutera Jumped Today

2019-08-08 23:24:01 | Cutera CUTR Q2 2019 Earnings Call Transcript

2019-08-08 17:55:09 | Cutera CUTR Beats Q2 Earnings and Revenue Estimates

2019-08-08 16:05:00 | Cutera Reports Second Quarter 2019 Financial Results

2019-08-01 10:33:02 | Analysts Estimate Cutera CUTR to Report a Decline in Earnings: What to Look Out for

2019-07-23 20:00:00 | Cutera Receives ANVISA Approval of truSculpt® Body Sculpting Systems in Brazil

2019-07-22 16:05:00 | Cutera, Inc. to Announce Second Quarter 2019 Results

2019-07-09 08:30:00 | Cutera Announces Appointment of David Mowry as Chief Executive Officer

2019-07-08 08:38:16 | Is Now The Time To Look At Buying Cutera, Inc. NASDAQ:CUTR?

2019-06-26 08:30:00 | Cutera Redefines the Muscle Sculpting Market with US Commercial Launch of truSculpt® flex

2019-06-25 21:24:34 | Here’s What Hedge Funds Think About Cutera, Inc. CUTR

2019-05-31 17:31:31 | 7 Stocks for You to Profit From Legal Insider Trading

2019-05-24 08:41:08 | If You Had Bought Cutera NASDAQ:CUTR Stock Five Years Ago, You Could Pocket A 76% Gain Today

2019-05-10 20:00:00 | Cutera to Provide truSculpt® iD and Laser Genesis® Aesthetic Treatments at the DPA Cannes Gift Lounge During the 72nd Festival de Cannes

2019-05-09 19:17:28 | Edited Transcript of CUTR earnings conference call or presentation 9-May-19 8:30pm GMT

2019-05-09 18:55:10 | Cutera CUTR Reports Q1 Loss, Tops Revenue Estimates

2019-05-09 17:43:39 | Cutera: 1Q Earnings Snapshot

2019-05-09 16:05:00 | Cutera Reports First Quarter 2019 Financial Results

2019-05-02 10:32:02 | Earnings Preview: Cutera CUTR Q1 Earnings Expected to Decline

2019-04-18 16:05:00 | Cutera, Inc. to Announce First Quarter 2019 Results

2019-04-17 20:00:00 | Cutera Announces Regulatory Approval of Secret™ RF Microneedling System in Canada

2019-03-18 19:48:04 | Cutera Inc CUTR Files 10-K for the Fiscal Year Ended on December 31, 2018

2019-02-28 07:46:12 | New Strong Sell Stocks for February 28th

2019-02-26 10:06:36 | Cutera Announces Global Commercial Launch Of the excel V+® the Next Generation Laser Platform

2019-02-26 07:25:00 | Market Trends Toward New Normal in Infinera, Alliant Energy, Galectin Therapeutics, DexCom, Cutera, and Care — Emerging Consolidated Expectations, Analyst Ratings

2019-02-21 13:29:16 | Edited Transcript of CUTR earnings conference call or presentation 20-Feb-19 9:30pm GMT

2019-02-20 19:48:59 | Cutera Inc CUTR Q4 2018 Earnings Conference Call Transcript

2019-02-20 19:00:12 | Cutera CUTR Reports Q4 Loss, Lags Revenue Estimates

2019-02-20 18:06:42 | Cutera: 4Q Earnings Snapshot

2019-02-20 16:06:00 | Cutera Appoints Katherine Zanotti and Joseph Whitters to its Board of Directors

2019-02-20 16:05:00 | Cutera Reports Fourth Quarter and Full Year 2018 Financial Results

2019-02-13 10:31:03 | Earnings Preview: Cutera CUTR Q4 Earnings Expected to Decline

2019-01-30 08:30:00 | Cutera, Inc. to Announce Fourth Quarter and Full-Year 2018 Results

2019-01-18 08:12:24 | How Does Cutera, Inc. NASDAQ:CUTR Affect Your Portfolio Volatility?

2019-01-07 08:45:00 | Cutera CEO resigns after results 'dissatisfied' board

2019-01-07 08:30:00 | Cutera Announces Leadership Change and Preliminary Financial Results for Full Year 2018

2018-12-26 07:10:38 | How Many Insiders Sold Cutera, Inc. NASDAQ:CUTR Shares?

2018-12-22 02:57:37 | Do Hedge Funds Love Cutera, Inc. CUTR?

2018-12-17 08:00:00 | Cutera Announces Expansion of FDA Indications for enlighten™ Laser Platform

2018-12-03 09:04:02 | What does Cutera Inc’s NASDAQ:CUTR Balance Sheet Tell Us About Its Future?

2018-11-28 07:25:00 | Consolidated Research: 2018 Summary Expectations for Ocwen Financial, Inovalon, Reading International, Cutera, Sunrun, and Pilgrim's Pride — Fundamental Analysis, Key Performance Indications